At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CTEV Claritev Corporation
Post-Mkt 09-09 16:22:42 EDT
36.29
-1.42
-3.77%
盘后36.29
+0.000.00%
16:10 EDT
High37.71Low35.66Vol119.20K
Open37.71D1 Closing37.71Amplitude5.45%
Mkt Cap615.73MTradable Cap204.59MTotal Shares16.97M
T/O4.34MT/O Rate2.11%Tradable Shares5.64M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Claritev Says Healthcare Pricing Intelligence Turns Transparency Data into Operational Cost-Management Tool
Reuters  ·  09-09 20:15
Claritev Says Healthcare Pricing Intelligence Turns Transparency Data into Operational Cost-Management Tool
Claritev CEO and Executive Chair Dalton Travis Reports $249,909 Purchase of Common Shares
Reuters  ·  08-31
Claritev CEO and Executive Chair Dalton Travis Reports $249,909 Purchase of Common Shares
Claritev Management to Present at Morgan Stanley Global Healthcare Conference
Reuters  ·  08-27
Claritev Management to Present at Morgan Stanley Global Healthcare Conference
U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions
Reuters  ·  08-21
U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions
Claritev price target raised to $40 from $28 at Barclays
TIPRANKS  ·  08-21
Claritev price target raised to $40 from $28 at Barclays
Claritev Chief Growth Officer Tiffani Misencik Sells 8,850 Shares Worth $354,592.95
Reuters  ·  08-19
Claritev Chief Growth Officer Tiffani Misencik Sells 8,850 Shares Worth $354,592.95
Claritev Shifts Payment Integrity Strategy Toward Pre-Pay Overpayment Prevention to Boost ROI
Reuters  ·  08-18
Claritev Shifts Payment Integrity Strategy Toward Pre-Pay Overpayment Prevention to Boost ROI
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
THOMSON REUTERS  ·  08-17
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
Claritev Expands Marpai Partnership to Add Pre- and Post-Payment Claims Integrity Services
Reuters  ·  08-17
Claritev Expands Marpai Partnership to Add Pre- and Post-Payment Claims Integrity Services
Multiplan Board Authorizes Management to Proceed with Annual Business Plan Implementation
Reuters  ·  08-15
Multiplan Board Authorizes Management to Proceed with Annual Business Plan Implementation
Claritev SVP, Chief Strategy Officer William B. Mintz Sells 8,431 Common Shares for $288,277.44
Reuters  ·  08-13
Claritev SVP, Chief Strategy Officer William B. Mintz Sells 8,431 Common Shares for $288,277.44
Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
Dow Jones  ·  08-12
Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
Claritev Analysts Raise Their Forecasts Following Q2 Earnings
Benzinga Earnings  ·  08-10
Claritev Analysts Raise Their Forecasts Following Q2 Earnings
Claritev Shifts Strategy to Earlier Cost Intelligence to Cut Avoidable Healthcare Spending
Reuters  ·  08-10
Claritev Shifts Strategy to Earlier Cost Intelligence to Cut Avoidable Healthcare Spending
Claritev is Maintained at Buy by Canaccord Genuity
Dow Jones  ·  08-10
Claritev is Maintained at Buy by Canaccord Genuity
Guggenheim Sticks to Its Buy Rating for Claritev (CTEV)
TIPRANKS  ·  08-10
Guggenheim Sticks to Its Buy Rating for Claritev (CTEV)
Claritev price target raised to $45 from $40 at Citi
TIPRANKS  ·  08-10
Claritev price target raised to $45 from $40 at Citi
Analysts Offer Insights on Healthcare Companies: Claritev (CTEV) and Qiagen (QGEN)
TIPRANKS  ·  08-10
Analysts Offer Insights on Healthcare Companies: Claritev (CTEV) and Qiagen (QGEN)
Claritev Corp : Canaccord Genuity Raises Target Price to $43 from $37
THOMSON REUTERS  ·  08-10
Claritev Corp : Canaccord Genuity Raises Target Price to $43 from $37
Claritev Corp Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  08-07
Claritev Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Introduction

Company Name.
Claritev Corporation
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets clients' needs and customizes innovative solutions that combine its payment integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, dental, government and property and casualty markets. For more information, visit multiplan.com.
Issue price:
--